![]() | Harrison Graham PopeBiological Psychiatry Laboratory, Harvard Medical School, McLean Hospital, Massachusetts, USA | Harvard Medical School, Boston, Massachusetts. | Biological Psychiatry ... |
KOL Resume for Harrison Graham Pope
Year | |
---|---|
2021 | Biological Psychiatry Laboratory, Harvard Medical School, McLean Hospital, Massachusetts, USA Harvard Medical School, Boston, Massachusetts. |
2020 | Harvard Medical School, Boston, Massachusetts, USA, Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts, USA. |
2019 | Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts |
2018 | Department of Psychiatry, Massachusetts General Hospital, Boston; Department of Psychiatry, McLean Hospital, Belmont, MA; Department of Psychiatry, Harvard Medical School, Boston, MA; and Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA. From the Biological Psychiatry Laboratory,McLean Hospital/Harvard Medical School,115 Mill St,Belmont,Massachusetts 02478,USA. McLean Hospital/Harvard Medical School, Belmont, MA, USA; Harvard Medical School, Boston, Massachusetts |
2017 | From Cardiovascular Performance Program, Division of Cardiology, Massachusetts General Hospital, Boston (A.L.B., R.B.W.); Department of Medicine, Harvard Medical School, Boston, MA (A.L.B., R.B.W.); Biological Psychiatry Laboratory and Psychiatric Epidemiology Research Program, McLean Hospital, Belmont, MA (G.K., J.I.H., H.G.P.); Department of Psychiatry, Harvard Medical School, Boston, MA (G.K., J.I.H., H.G.P.); Cardiac MR PET CT Program, Massachusetts General Hospital and Department of Radiology, Harvard Medical School, Boston (M.T.L., U.H.). Department of Psychiatry, Harvard Medical School, Boston, MA, USA Biological Psychiatry Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts |
2016 | Biological Psychiatry Laboratory, McLean Hospital, Belmont Department of Psychiatry, Harvard Medical School, Boston |
2015 | Department of Public Health Sciences, Section for Epidemiology and Public Health Intervention Research (EPHIR), Karolinska Institutet, Department of Clinical Neuroscience, Karolinska Institutet, and, Institute of Environmental Medicine, Unit of Occupational Medicine, Karolinska Institutet, Stockholm, Sweden;, Biological Psychiatry Laboratory, McLean Hospital, Belmont, Mass., and Department of Psychiatry, Harvard Medical School, Boston, Mass., USA Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA, United States |
2014 | Biological Psychiatry Laboratory, Department of Psychiatry, McLean Hospital, Harvard Medical School, 115 Mill Street, 02478, Belmont, MA, USA Harvard Medical School, United States |
2013 | From the *Biological Psychiatry Laboratory, McLean Hospital, Belmont; †Department of Psychiatry, Harvard Medical School, Boston; ‡Shervert Frazier Research Institute, and §Brain Imaging Center, McLean Hospital, Belmont, MA; and ∥Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT. Department of Psychiatry; Harvard Medical School; Boston Massachusetts McLean Hospital, Belmont, MA, USA |
2012 | McLean Hospital, Harvard Medical School, Belmont, MA;Bridgewater State University, MA; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA |
2011 | Biological Psychiatry Laboratory, McLean Hospital; and the Department of Psychiatry, Harvard Medical School, Boston, Massachusetts |
2010 | 1From the Biological Psychiatry Laboratory McLean Hospital Belmont MAthe Department of Psychiatry Harvard Medical School Boston MA (JIH JKL CECHGP); the Institute of Behavioral Genomics Department of Psychiatry University of California at San Diego San Diego CAthe Harvard Institute of Psychiatric Epidemiology & Genetics Boston MA (MTT); the Lindner Center of HOPE Mason OHthe Department of Psychiatry University of Cincinnati College of Medicine Cincinnati OH (SLM); the Department of Psychiatry University of Minnesota Minneapolis MN (SJC); the Departments of PsychiatryNutrition University of North Carolina at Chapel Hill Chapel Hill NC (CMB); the Division of Endocrinology BrighamWomen's Hospital Boston MAthe Department of Medicine Harvard Medical School Boston MA (MSH); the Unit on GrowthObesity Program in Developmental EndocrinologyGenetics Eunice Kennedy Shriver National Institute of Child HealthHuman Development National Institutes of Health Bethesda MD (JAY);Ortho-McNeil Pharmaceutical Inc Raritan NJ (NRR). From the Division of Cardiology (A.L.B., R.B.W., M.H.P., A.M.H.), Massachusetts General Hospital, and Department of Medicine (A.L.B., R.B.W., M.H.P., A.M.H.), Harvard Medical School, Boston, Mass; Biological Psychiatry Laboratory (G.K., J.I.H., H.G.P.), McLean Hospital, Belmont, Mass; and Department of Psychiatry (G.K., J.I.H., H.G.P.), Harvard Medical School, Boston, Mass. McLean Hospital, Harvard Medical School, Belmont, MA Department of Psychiatry, Harvard Medical School |
2009 | Biological Psychiatry Laboratory, McLean Hospital, Belmont, and Harvard Medical School, Boston, MA, USA Belmont, Mass. |
2008 | Harvard Medical School, Boston Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA |
2007 | Department of Psychiatry, Harvard Medical School, Boston, MA |
2006 | Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478, USA. Biological Psychiatry Laboratory, McLean Hospital/Harvard Medical School, Belmont, MA 02478, USA |
2005 | McLean Hospital, Harvard Medical School, Belmont, MA, USA |
2004 | Biological Psychiatry Laboratory, McLean Hospital/Harvard Medical School, 115 Mill St., MA 02478, Belmont, USA Department of Psychiatry, Harvard Medical School, Belmont, Massachusetts |
2003 | Department of Psychiatry, Harvard Medical School, Belmont, MA 02478, USA Biological Laboratory of Psychiatry, McLean Hospital, Belmont, Massachusetts |
2002 | Biological Psychiatry Laboratory, McLean Hospital/Harvard Medical School, Belmont, Massachusetts Department of Social Sciences, Loughborough University, Leicestershire LE11 3TU, UK |
Harrison Graham Pope: Influence Statistics
Concept | World rank |
---|---|
bulimic subjects | #1 |
abstinence heavy cannabis | #1 |
recommendations abusers | #1 |
patients chez | #1 |
behaviors aas | #1 |
boulimiques trouble | #1 |
aas viral | #1 |
unrealistic body ideals | #1 |
88 users | #1 |
shortterm residual effects | #1 |
aas physicians | #1 |
male body women | #1 |
dependent aas users | #1 |
10×109 case | #1 |
sex 2d4d ratios | #1 |
aasusing recreationals | #1 |
induced violence | #1 |
ems ltryptophan | #1 |
fibromyalgia eosinophiliamyalgia syndrome | #1 |
years questionnaire study | #1 |
dissimulating disorders | #1 |
selfadminister aas | #1 |
respondents current stage | #1 |
testosterone cypionate | #1 |
aas authors | #1 |
study 27 12 | #1 |
ejaculatory ability life | #1 |
muscle dysmorphia anabolic | #1 |
small musculature | #1 |
hormones aas | #1 |
aas dependence individuals | #1 |
108 male bodybuilders | #1 |
dose anabolic | #1 |
findings media images | #1 |
widespread aas | #1 |
mood disorders disorders | #1 |
gay bisexual aas | #1 |
mass skeletal periodicals | #1 |
advertising women magazines | #1 |
competitors recreationals | #1 |
medications antidepressant | #1 |
testosterone subgroup | #1 |
stable syndrome | #1 |
antidepressants theoretical considerations | #1 |
affective spectrum disorder | #1 |
antidepressants binge | #1 |
bodybuilders competitive | #1 |
frank major depression | #1 |
aas dependence | #1 |
drug life style | #1 |
Open the FULL List in Excel | |
Prominent publications by Harrison Graham Pope
Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers
[ PUBLICATION ]
BACKGROUND: Anabolic-androgenic steroid (AAS) dependence has been a recognized syndrome for some 20 years, but remains poorly understood.
METHODS: We evaluated three groups of experienced male weightlifters: (1) men reporting no history of AAS use (N=72); (2) nondependent AAS users reporting no history of AAS dependence (N=42); and (3) men meeting adapted DSM-IV criteria for current or past AAS dependence (N=20). We assessed demographic indices, lifetime history of psychiatric disorders ...
Known for Aas Nonusers | Androgenic Steroid | Psychiatric Disorders | Conduct Disorder | Substance Dependence |
We have reviewed studies examining the efficacy of various psychotropic medications, primarily antidepressant agents, in the treatment of a group of disorders that appear to exhibit some phenomenologic and genetic relationship to major depression. These disorders all appear to benefit (albeit to varying degrees) from antidepressant medications of several different chemical families. This observation has important theoretical and clinical implications. From a theoretical perspective, ...
Known for Irritable Bowel Syndrome | Major Depression | Atypical Facial Pain | Chronic Fatigue | Antidepressant Medications |
AIMS: To assess anabolic-androgenic steroid (AAS) users' trust in the knowledge and advice of physicians.
DESIGN: Interviews of AAS users and non-users.
SETTING: Research offices.
PARTICIPANTS: Eighty weight-lifters (43 AAS users, 37 non-users) recruited by advertisement in Massachusetts and Florida, USA.
MEASUREMENTS: Personal interviews and questionnaire responses, including subjects' ratings of physicians' knowledge regarding various health- and drug-related topics. AAS users also ...
Known for Aas Users | Anabolic Steroid | Illicit Drugs | Substance Disorders | Dietary Supplements |
OBJECTIVE: Body image disorders appear to be more prevalent in Western than non-Western men. Previous studies by the authors have shown that young Western men display unrealistic body ideals and that Western advertising seems to place an increasing value on the male body. The authors hypothesized that Taiwanese men would exhibit less dissatisfaction with their bodies than Western men and that Taiwanese advertising would place less value on the male body than Western media.
METHOD: The ...
Known for Male Body | United States | Continental Ancestry | Image Disorders | Cross Cultural |
BACKGROUND: Affective spectrum disorder (ASD) represents a group of psychiatric and medical conditions, each known to respond to several chemical families of antidepressant medications and hence possibly linked by common heritable abnormalities. Forms of ASD include major depressive disorder (MDD), attention-deficit/hyperactivity disorder, bulimia nervosa, cataplexy, dysthymic disorder, fibromyalgia, generalized anxiety disorder, irritable bowel syndrome, migraine, obsessive-compulsive ...
Known for Forms Asd | Affective Spectrum Disorder | Familial Aggregation | Bulimia Nervosa | Social Phobia |
The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication
[ PUBLICATION ]
BACKGROUND: Little population-based data exist on the prevalence or correlates of eating disorders.
METHODS: Prevalence and correlates of eating disorders from the National Comorbidity Replication, a nationally representative face-to-face household survey (n = 9282), conducted in 2001-2003, were assessed using the WHO Composite International Diagnostic Interview.
RESULTS: Lifetime prevalence estimates of DSM-IV anorexia nervosa, bulimia nervosa, and binge eating disorder are .9%, 1.5%, ...
Known for Eating Disorders | Prevalence Correlates | National Comorbidity | Onset Bulimia Nervosa | Survey Replication |
Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole
[ PUBLICATION ]
Glutamatergic abnormalities may underlie bipolar disorder (BD). The glutamate-modulating drug riluzole may be efficacious in bipolar depression, but few in vivo studies have examined its effect on glutamatergic neurotransmission. We conducted an exploratory study of the effect of riluzole on brain glutamine/glutamate (Gln/Glu) ratios and levels of N-acetylaspartate (NAA). We administered open-label riluzole 100–200 mg daily for 6 weeks to 14 patients with bipolar depression and obtained ...
Known for Bipolar Depression | Glutamatergic Neurotransmission | Gln Glu | Baseline Week | Treatment Riluzole |
The current approach to detection of doping with testosterone is based on measuring the testosterone to epitestosterone ratio (T/E) in urine by gas chromatography/mass spectrometry. The median T/E for healthy males who have not used T is about 1.0. In a single urine, a T/E lower than six leads to a negative report even though it does not exclude T administration. A value greater than six indicates possible T administration or a naturally elevated ratio. It has been shown previously that ...
Known for Isotope Ratio | Spectrometry Analysis | Detection Testosterone | Gas Chromatography | Urinary Steroids |
Fluvoxamine in the Treatment of Binge-Eating Disorder: A Multicenter Placebo-Controlled, Double-Blind Trial
[ PUBLICATION ]
OBJECTIVE: The purpose of this study was to assess the efficacy of fluvoxamine in the treatment of binge-eating disorder. Binge-eating disorder is a newly described eating disorder characterized by recurrent episodes of binge eating but without purging behaviors. Uncontrolled reports have suggested that serotonin selective reuptake inhibitors (SSRIs) may be effective in treating this disorder.
METHOD: Eighty-five outpatients with a DSM-IV diagnosis of binge-eating disorder were randomly ...
Known for Eating Disorder | Fluvoxamine Treatment | Reduction Frequency | Outcome Measures | Blind Trial |
PURPOSE: Patients with fibromyalgia have been reported to display high rates of several concomitant medical and psychiatric disorders, including migraine, irritable bowel syndrome, chronic fatigue syndrome, major depression, and panic disorder. To test further these and other possible associations, we assessed the personal and family histories of a broad range of medical and psychiatric disorders in patients with fibromyalgia.
PATIENTS AND METHODS: Subjects were 33 women (mean age 42.1 ...
Known for Psychiatric Disorders | Panic Disorder | Patients Fibromyalgia | Major Depression | Fatigue Syndrome |
OBJECTIVE: To assess whether frequent marijuana use is associated with residual neuropsychological effects.
DESIGN: Single-blind comparison of regular users vs infrequent users of marijuana.
PARTICIPANTS: Two samples of college undergraduates: 65 heavy users, who had smoked marijuana a median of 29 days in the last 30 days (range, 22 to 30 days) and who also displayed cannabinoids in their urine, and 64 light users, who had smoked a median of 1 day in the last 30 days (range, 0 to 9 ...
Known for Heavy Marijuana | College Students | Residual Cognitive Effects | Neuropsychological Tests | Regular Users |
Key People For Bulimia Nervosa
Harrison Graham Pope:Expert Impact
Concepts for whichHarrison Graham Popehas direct influence:Bulimia nervosa, Eating disorders, Bipolar disorder, Body image, Anorexia nervosa, Major affective disorder, Muscle dysmorphia, Neuroleptic malignant syndrome.
Harrison Graham Pope:KOL impact
Concepts related to the work of other authors for whichfor which Harrison Graham Pope has influence:Bipolar disorder, Anorexia nervosa, Body image, Binge eating, Depressive symptoms, Compulsive buying, Neuroleptic malignant syndrome.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |